EMAIL THIS PAGE TO A FRIEND

The Journal of physiology

Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise.


PMID 25640469

Abstract

AMP-activated protein kinase (AMPK) is a regulator of energy homeostasis during exercise. Studies suggest muscle fibre type-specific AMPK expression. However, fibre type-specific regulation of AMPK and downstream targets during exercise has not been demonstrated. We hypothesized that AMPK subunits are expressed in a fibre type-dependent manner and that fibre type-specific activation of AMPK and downstream targets is dependent on exercise intensity. Pools of type I and II fibres were prepared from biopsies of vastus lateralis muscle from healthy men before and after two exercise trials: (1) continuous cycling (CON) for 30 min at 69 ± 1% peak rate of O2 consumption (V̇O2 peak ) or (2) interval cycling (INT) for 30 min with 6 × 1.5 min high-intensity bouts peaking at 95 ± 2% V̇O2 peak . In type I vs. II fibres a higher β1 AMPK (+215%) and lower γ3 AMPK expression (-71%) was found. α1 , α2 , β2 and γ1 AMPK expression was similar between fibre types. In type I vs. II fibres phosphoregulation after CON was similar (AMPK(Thr172) , ACC(Ser221) , TBC1D1(Ser231) and GS(2+2a) ) or lower (TBC1D4(Ser704) ). Following INT, phosphoregulation in type I vs. II fibres was lower (AMPK(Thr172) , TBC1D1(Ser231) , TBC1D4(Ser704) and ACC(Ser221) ) or higher (GS(2+2a) ). Exercise-induced glycogen degradation in type I vs. II fibres was similar (CON) or lower (INT). In conclusion, a differentiated response to exercise of metabolic signalling/effector proteins in human type I and II fibres was evident during interval exercise. This could be important for exercise type-specific adaptations, i.e. insulin sensitivity and mitochondrial density, and highlights the potential for new discoveries when investigating fibre type-specific signalling.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB4200102
Anti-AS160 (C-terminal) antibody produced in rabbit, ~1.5 mg/mL
SAB4200101
Anti-AS160 antibody produced in rabbit, ~1.5 mg/mL, affinity isolated antibody
SAB4503722
Anti-AS160 antibody produced in rabbit, affinity isolated antibody
SAB1400126
Anti-HLA-E antibody produced in mouse, IgG fraction of antiserum, buffered aqueous solution
SAB1401182
Anti-HLA-E antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
HPA031454
Anti-HLA-E antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB1407187
Anti-TBC1D1 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
PRS4231
Anti-TBC1D1 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB2900287
Anti-TBC1D1 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB2102373
Anti-TBC1D1 antibody produced in rabbit, affinity isolated antibody
HPA041816
Anti-TBC1D1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
12156
Density Standard 998 kg/m3, H&D Fitzgerald Ltd. Quality
H2O
S5386
DL-Serine, BioReagent, suitable for cell culture, suitable for insect cell culture, ≥98% (HPLC)
C3H7NO3
S4375
DL-Serine, ≥98% (TLC)
C3H7NO3
T8625
L-Threonine, reagent grade, ≥98% (HPLC)
C4H9NO3
T8441
L-Threonine, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, 99.0-101.0%
C4H9NO3
T4071
L-Threonine, PharmaGrade, Ajinomoto, EP, JP, USP, manufactured under appropriate GMP controls for Pharma or Biopharmaceutical production, suitable for cell culture
C4H9NO3
89179
L-Threonine, BioXtra, ≥99.5% (NT)
C4H9NO3
61506
L-Threonine, certified reference material, TraceCERT®
C4H9NO3
PHR1242
L-Threonine, Pharmaceutical Secondary Standard; Certified Reference Material
C4H9NO3
T1340000
L-Threonine, European Pharmacopoeia (EP) Reference Standard
C4H9NO3
WH0000031M1
Monoclonal Anti-ACACA antibody produced in mouse, clone 6H5, purified immunoglobulin, buffered aqueous solution
SAB4700300 Monoclonal Anti-HLA-E antibody produced in mouse, clone MEM-E/08, purified immunoglobulin, buffered aqueous solution
SAB4700301 Monoclonal Anti-HLA-E antibody produced in mouse, clone MEM-E/06, purified immunoglobulin, buffered aqueous solution
SAB4700302 Monoclonal Anti-HLA-E antibody produced in mouse, clone MEM-E/07, purified immunoglobulin, buffered aqueous solution
N5535
Niacinamide, meets USP testing specifications
C6H6N2O
PHR1033
Niacinamide, Pharmaceutical Secondary Standard; Certified Reference Material
C6H6N2O
1462006
Niacinamide, United States Pharmacopeia (USP) Reference Standard
C6H6N2O
72340
Nicotinamide, ≥99.5% (HPLC)
C6H6N2O
N3376
Nicotinamide, ≥98% (HPLC), powder
C6H6N2O